- All sections
- A - Human necessities
- A61M - Devices for introducing media into, or onto, the bodydevices for transducing body media or for taking media from the bodydevices for producing or ending sleep or stupor
- A61M 60/17 - Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient’s body implantable in, on, or around the heart inside a ventricle, e.g. intraventricular balloon pumps
Patent holdings for IPC class A61M 60/17
Total number of patents in this class: 172
10-year publication summary
0
|
0
|
2
|
4
|
7
|
27
|
14
|
27
|
50
|
33
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
ABIOMED, Inc. | 755 |
26 |
Magenta Medical Ltd. | 173 |
14 |
Boston Scientific Scimed, Inc. | 10291 |
13 |
Miracor Medical SA | 57 |
11 |
Cardiacbooster B.V. | 21 |
8 |
Abiomed Europe GmbH | 249 |
6 |
Fineheart | 66 |
4 |
Royal College of Surgeons in Ireland | 113 |
4 |
Kardion GmbH | 167 |
4 |
Aria CV, Inc. | 32 |
3 |
Berlin Heart GmbH | 189 |
3 |
ECP Entwicklungsgesellschaft mbH | 230 |
3 |
Tc1 LLC | 633 |
3 |
Supira Medical, Inc. | 53 |
3 |
Rocketheart Technology Co. Ltd. | 9 |
3 |
Shenzhen Core Medical Technology Co.,Ltd. | 54 |
3 |
Puzzle Medical Devices Inc. | 34 |
3 |
Medtronic, Inc. | 9817 |
2 |
CardioFlow Technologies, LLC | 18 |
2 |
Edwards Lifesciences Corporation | 4726 |
2 |
Other owners | 52 |